Oral Cancer Treatment Market to Reach $2.72 Bn, Globally, by 2030 at 4.8% CAGR

Rise in prevalence of oral cancer and surge in government expenditure on healthcare drive the growth of the global oral cancer treatment market

PORTLAND, Ore., Jan. 17, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Oral Cancer Treatment Market by Treatment (Chemotherapy, Immunotherapy, and Targeted Therapy), Age Group (30-49, 50-69 and 70<), and End User (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Store): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global oral cancer treatment market was valued at $1.71 billion 2020, and is expected to reach $2.72 billion by 2030, witnessing a CAGR of 4.8% from 2021 to 2030.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/15272

Drivers, restraints, and opportunities

Rise in prevalence of oral cancer and surge in government expenditure on healthcare drive the growth of the global oral cancer treatment market. However, adverse effects regarding usage of cancer drugs hinder the market growth. On the other hand, rise in number of pipeline drugs and untapped potential in emerging countries create new opportunities in the coming years.

Covid-19 Scenario

• Dentists play a crucial role in detection of oral cancer through screening of oral cavities. The closure of dental clinics during the lockdown led to reduced detection activities, which in turn, impacted the treatment measures.
• There has been postponement of elective surgeries during the pandemic to prevent cross-contamination. Surgeries were conducted only for malignant or potentially malignant lesions only. Else, surgeries were postponed.

The chemotherapy segment to continue its leadership status during the forecast period

Based on drug type, the chemotherapy segment accounted for the highest share in 2020, contributing to around two-thirds of the global oral cancer treatment market, and is estimated to continue its leadership status during the forecast period. This type of treatment is provided every day for the course of six weeks according to the size of the cancer and its spread. This results in the highest revenue generation. However, the targeted therapy segment is expected to witness the largest CAGR of 5.5% from 2021 to 2030.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/15272

The hospital pharmacies segment to continue its dominance during the forecast period

Based on end user, the hospital pharmacies segment held the highest share in 2020, accounting for more than half of the global oral cancer treatment market, and is projected to continue its dominance in terms of revenue during the forecast period. Moreover, this segment is expected to portray the highest CAGR of 4.9% from 2021 to 2030. As patients are admitted to hospitals for chemotherapy and other treatments, it becomes easier for them to get the medicines prescribed from hospital pharmacies as compared to other stores. This leads to the highest revenue generation. The research also analyzes the segments including drug stores & retail pharmacies and online stores.

North America to maintain its lead position by 2030

Based on region, North America contributed to the highest market share in 2020, accounting for nearly two-fifths of the global oral cancer treatment market, and is expected to maintain its lead position by 2030. This is due to rise in healthcare investments and prevalence of oral cancer in the region. However, LAMEA is expected to manifest the fastest CAGR of 6.3% during the forecast period.

Leading market players

• Bristol-Myers Squibb Company
• Cipla Inc.
• Eli-Lilly
• F. Hoffmann-La Roche
• Fresenius Kabi AG
• Intas Pharmaceuticals Ltd, Merck & Co., Inc.
• Sanofi
• Teva Pharmaceuticals Industries Ltd.
• Viatris Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Orthodontics Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Intraoral Scanners Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Oral Proteins and Peptides Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Oral Thin Film Drugs Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Oral Antibiotics Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Oral Antiviral Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Dental Intraoral Camera Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Anti-Oral Mucositis Drug Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Dental Equipment Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

Dental Implants Market - Global Opportunity Analysis and Industry Forecast, 2019–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg